MedTrace Logo

Pilot Study of Targeted Normoxia in Critically Ill Trauma Patients

NCT03789396 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 572

Last updated 2024-02-15

Study results available
· View outcomes & findings →

Summary

The objective of this study is to conduct an observational pre/post study to evaluate the clinical impact oxygen guideline implementation on oxygen utilization and oxygenation in critically ill trauma patients.

Conditions

  • Trauma
  • Critical Illness
  • Oxygen Toxicity

Interventions

OTHER

Targeted Normoxia (oxygen saturation 90-96%)

The intervention (post-implementation) group will be trauma patients admitted to the ICU during the 6 months after the targeted normoxia implementation

OTHER

Usual Care Oxygenation

The control (pre-implementation) group will be trauma patients admitted to the ICU during the 12 months prior to the targeted normoxia implementation

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Adit Ginde, MD, MPH · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
109 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-09-19
Completion
2022-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03789396 on ClinicalTrials.gov